BAXTER HEALTHCARE (ASIA) PTE LTD

<p><strong>4.1 Therapeutic indications</strong></p> <p>PeriOLIMEL N4E is indicated for parenteral nutrition for adults and children greater than 2 years of age when oral or enteral nutrition is impossible, insufficient or contraindicated.</p>

<p><strong>4.1 Therapeutic indications</strong></p> <p>OLIMEL N7E is indicated for parenteral nutrition for adults and children greater than 2 years of age when oral or enteral nutrition is impossible, insufficient or contraindicated.</p>

<p><strong>4.1 Therapeutic indications</strong></p> <p>OLIMEL N9E is indicated for parenteral nutrition for adults and children greater than 2 years of age when oral or enteral nutrition is impossible, insufficient or contraindicated.</p>

<p><strong>Indications and Usage</strong><br> 0.9% Sodium Chloride Injection, USP is indicated as a source of water and electrolytes.<br> 0.9% Sodium Chloride Injection, USP is also indicated for use as a priming solution in hemodialysis procedures.</p>

**4.1 Therapeutic indications** PHOXILIUM solution is used for CRRT (Continuous Renal Replacement Therapy) in critically ill patients with ARF (Acute Renal Failure) when pH and kalaemia have been restored to normal and when the patients need phosphate supplementation for loss of phosphate in the ultrafiltrate or to the dialysate during CRRT. PHOXILIUM solution may also be used in cases of drug poisoning or intoxications when the poisons are dialyzable or pass through the membrane. PHOXILIUM solution is indicated for use in patients with normal kalaemia and normal or hypophosphataemia.

**4.1 THERAPEUTIC INDICATIONS** **Biphozyl** solution is used as replacement solution and as dialysate for treatment of acute kidney injury during continuous renal replacement therapy (CRRT). **Biphozyl** solution is used in a post-acute phase after initiation of renal replacement therapy when pH, potassium and phosphate concentration have returned to normal. **Biphozyl** solution is also used when other buffer sources are available as well as during regional citrate anticoagulation. Moreover, **Biphozyl** solution is used in patients with hypercalcaemia. **Biphozyl** solution may also be used in cases of drug poisoning or intoxications when the substances are dialysable or filterable.

**4.1 THERAPEUTIC INDICATIONS** **Regiocit** solution is indicated as replacement fluid before dialyzer for continuous renal replacement therapy (CRRT) using regional citrate anticoagulation. Citrate is particularly relevant when systemic anticoagulation with heparin is contraindicated, for example in patients with increased bleeding risks. In paediatric patients, **Regiocit** solution is indicated in all age groups provided that the equipment used is adapted to the weight of the child.